Gennex Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 26.15 | 27.35 | 26.51 |
| Operating Expense | 23.21 | 21.78 | 20.98 |
| Net Profit | 1.50 | 4.21 | 4.16 |
| Net Profit Margin | 5.74 | 15.39 | 15.69 |
| Earning Per Share | 0.07 | 0.19 | 0.18 |
| EBIDTA | 2.88 | 5.57 | 5.53 |
| Effective Tax Rate | 21.09 | 13.49 | 15.37 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 26.15 |
| Operating Expense | 23.21 |
| Net Profit | 1.50 |
| Net Profit Margin | 5.74 |
| Earning Per Share | 0.07 |
| EBIDTA | 2.88 |
| Effective Tax Rate | 21.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 66.80 | 65.10 | 61.21 |
| Operating Expenses Annual | 54.38 | 60.52 | 55.84 |
| Operating Profit Annual | 16.72 | 7.99 | 6.76 |
| Interest Annual | 1.16 | 1.23 | 0.88 |
| Depreciation | 0.81 | 0.74 | 0.79 |
| Net Profit Annual | 11.80 | 4.56 | 3.92 |
| Tax Annual | 2.96 | 1.45 | 1.17 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 66.80 |
| Operating Expenses Annual | 54.38 |
| Operating Profit Annual | 16.72 |
| Interest Annual | 1.16 |
| Depreciation | 0.81 |
| Net Profit Annual | 11.80 |
| Tax Annual | 2.96 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 14.45 | 8.31 | 1.07 |
| Cash Flow from Operations | -33.43 | -14.45 | 6.64 |
| Cash Flow from Investing | 0.93 | -0.77 | -1.26 |
| Cash Flow from Financing | 79.01 | 21.35 | 1.87 |
| Cash Flow at the End | 60.96 | 14.45 | 8.31 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 14.45 |
| Cash Flow from Operations | -33.43 |
| Cash Flow from Investing | 0.93 |
| Cash Flow from Financing | 79.01 |
| Cash Flow at the End | 60.96 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 22.59 | 11.20 | 10.36 |
| PBIT Margin (%) | 21.50 | 10.16 | 9.15 |
| PBT Margin (%) | 2.97 | 1.90 | -1.24 |
| Net PROFIT Margin (%) | 15.94 | 6.39 | 6.01 |
| Return On Networth / Equity (%) | 9.45 | 7.41 | 9.35 |
| Return On Networth /Employed (%) | 12.50 | 10.69 | 11.78 |
| Return On Assets (%) | 9.24 | 6.71 | 7.75 |
| Total Debt / Equity (X) | 0.01 | 0.09 | 0.21 |
| Asset Turnover Ratio (%) | 0.58 | 1.05 | 1.29 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 22.59 |
| PBIT Margin (%) | 21.50 |
| PBT Margin (%) | 2.97 |
| Net PROFIT Margin (%) | 15.94 |
| Return On Networth / Equity (%) | 9.45 |
| Return On Networth /Employed (%) | 12.50 |
| Return On Assets (%) | 9.24 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 15.83 | 15.18 | 13.70 |
| Total Current Assets Annual | 178.99 | 72.16 | 47.18 |
| Non Current Assets Annual | 26.35 | 24.06 | 21.03 |
| Total Shareholders Funds Annual | 170.76 | 79.02 | 44.00 |
| Total Assets Annual | 205.34 | 96.22 | 68.21 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 15.83 |
| Total Current Assets Annual | 178.99 |
| Non Current Assets Annual | 26.35 |
| Total Shareholders Funds Annual | 170.76 |
| Total Assets Annual | 205.34 |
EPS (INR)
Expected
0.10
Reported
0.14
Surprise
40.00%
Dec 2024
EPS beaten by 40.00%
Sep 2024
EPS beaten by 10.00%
Jun 2024
EPS beaten by 0.00%
